Uploaded October 2026 | Updated November 2026, 5 days ago
An experimental mRNA cancer vaccine from drug makers Merck and Moderna appears to help cut the chances of a melanoma tumour returning, according to the results of a new clinical trial.
The National is the flagship of CBC News showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault, our team of trusted reporters helps you make sense of the world, wherever you are.
Subscribe to get the latest news daily, and watch live starting at 9 p.m. ET.
youtube.com/user/CBCTheNational?sub_confirmation=1
More from CBC News | cbc.ca/news
An experimental mRNA cancer vaccine from drug makers Merck and Moderna appears to help cut the chances of a melanoma tumour returning, according to the results of a new clinical trial.
The National is the flagship of CBC News showcasing award-winning journalism from across Canada and around the world. Led by Chief Correspondent Adrienne Arsenault, our team of trusted reporters helps you make sense of the world, wherever you are.
Subscribe to get the latest news daily, and watch live starting at 9 p.m. ET.
youtube.com/user/CBCTheNational?sub_confirmation=1
More from CBC News | cbc.ca/news










